FDA Issues Guidance on Nonclinical Testing of Cancer Drugs

In a June 18 Federal Register notice, the FDA announced release of a Q&A to help stakeholders interpret international guidance on nonclinical evaluation of cancer drugs. The Q&A includes statements about reduction of animal use or use of in vitro alternatives in these studies. The Q&A is available on the FDA website.